[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-337881-105":59,"doc-detail-337881-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","notch3-as-a-prognostic-biomarker-and-its-correlation-with-immune-infiltration-in-gastrointestinal-cancers","NOTCH3 as a Prognostic Biomarker - and its Correlation with Immune Infiltration in Gastrointestinal Cancers","","NOTCH receptor 3 (NOTCH3) regulates transcription of oncogenes and tumor suppressor genes, impacting tumor development, invasion, maintenance, and chemotherapy resistance. The work investigates how NOTCH3 may drive immune infiltration in gastrointestinal cancers, using Western blot and PCR, Oncomine, TIMER, TIMER/GEPIA-based expression analyses, and Kaplan–Meier/PrognoScan/GEPIA prognostic evaluations. NOTCH3 is frequently overexpressed in gastrointestinal tumors and links to poor clinical prognosis, tumor purity, and immune infiltration levels across immune cell types.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/notch3-as-a-prognostic-biomarker-and-its-correlation-with-immune-infiltration-in-gastrointestinal-cancers/337881/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/notch3-as-a-prognostic-biomarker-and-its-correlation-with-immune-infiltration-in-gastrointestinal-cancers/337881.png","ImageObject",300,407,{"name":92,"@type":93},"Violet","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main goal of this study on NOTCH3?","Question",{"text":112,"@type":113},"To determine whether NOTCH3 can serve as a prognostic biomarker and to evaluate its correlation with immune infiltration in gastrointestinal cancers.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was NOTCH3 expression analyzed?",{"text":117,"@type":113},"NOTCH3 expression was assessed using Western blot and PCR, along with Oncomine and the TIMER resource.",{"name":119,"@type":110,"acceptedAnswer":120},"What prognostic relationship was found for NOTCH3?",{"text":121,"@type":113},"Higher NOTCH3 expression was significantly associated with poor clinical prognosis, as evaluated using Kaplan–Meier plotter, PrognoScan, and GEPIA.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},337881,1790531903,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4398048950312,"https://ap-avatar.wpscdn.com/avatar/400002538284de19e3c?_k=1778320343897328908","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nNOTCH3 as a prognostic biomarker and its correlation with immune infiltration in gastrointestinal cancers  \nJia Xu1, Xiao‑li Jin1, Hao Shen1, Xuan‑wei Chen1, Jin Chen1, Hui Huang1, Bin Xu2* & Jian Xu1*  \nNOTCH receptor 3 (NOTCH3) is known to regulate the transcription of oncogenes or tumor suppressor genes, thereby playing a crucial role in tumor development, invasion, maintenance, and chemotherapy resistance. However, the specific mechanism of how NOTCH3 drives immune infiltration in gastrointestinal cancer remains uncertain. The expression of NOTCH3 was analyzed through Western blot, PCR, Oncomine database, and the Tumor Immune Estimation Resource (TIMER) site. Kaplan–Meier plotter, PrognoScan database, and gene expression profile interactive analysis (GEPIA) were used to assess the impact of NOTCH3 on clinical prognosis. The correlation between NOTCH3 expression and immune infiltration gene markers was investigated using TIMER and GEPIA. NOTCH3 was found to be commonly overexpressed in various types of gastrointestinal tumors and was significantly associated with poor prognosis. Furthermore, the expression level of NOTCH3 showed a significant correlation with the tumor purity of gastrointestinal tumors and the extent of immune infiltration by different immune cells. Our findings suggest that NOTCH3 may act as a crucial regulator of tumor immune cell infiltration and can serve as a valuable prognostic biomarker in gastrointestinal cancers.  \nKeywords NOTCH3, Gastrointestinal cancers, Tumor infiltration, Immune  \nGastrointestinal tumors are a serious threat to people’s lives and health. Epidemiological studies1 show that the incidence of colorectal cancer ranks first in the world, the incidence of gastric cancer is the fifth, the mortality rate is the third2, and the incidence of liver cancer is 4.7%3. Ranked sixth in gastrointestinal tumors, pancreatic cancer is a globally recognized malignant tumor with a very poor prognosis, with a one-year survival rate of less than 40% after diagnosis4. Cancer metastasis is an important reason for the high mortality rate. Tumors effectively suppress the immune response by activating negative regulatory pathways related to immune homeostasis (also called checkpoints) or by adopting features that enable them to actively evade detection5–7.  \nImmune-related mechanisms, such as cytotoxic T lymphocyte associated antigen 4 (CTLA4), programmed death-1 (PD-1) and programmed death ligand-1 (PD-L1) inhibitors, play an important role in tumors. In melanoma, small cell lung cancer, and kidney cancer, specific PD-1 and PD-L1 immune checkpoint inhibitors (antiPD-L1/PD-1) have shown therapeutic effects beyond traditional radiotherapy and chemotherapy8. Surprisingly, some tumor patients who have received multiple standard treatment failures have sustained relief of symptoms and a significant increase in survival time after treatment with anti-PD-L1 and PD-19. In recent years, tumor immunotherapy has overturned the traditional tumor treatment methods based on surgery, radiotherapy and chemotherapy10. Ewa M Nowosielska11 found that whole-body irradiations (WBI) alone and in combination inhibits cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed death 1 (PD-1) receptor immune checkpoint (IC) and/or heat shock protein 90 (HSP90) significantly reduced mouse lung tumors, and inhibited the cloning potential of Lewis lung cancer (LLC1) cells in vitro.As reported that the tumor of a single colorectal cancer patient that response to PD-1 blockade has a mismatch repair defect 12. Therefore, it is reasonable to  \n1School of Medical Technology and Information Engineering, Zhejiang Chinese Medical University, Hangzhou 310053, Zhejiang, People’s Republic of China. 2Department of General Surgery, Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou 310016, Zhejiang, People’s Republic of China. *email:  \n[330408","cbCaiuaP9REtKoqi","https://ap.wps.com/l/cbCaiuaP9REtKoqi","pdf",5387623,14,"English","# Background\n## Immune checkpoints and tumor immunotherapy\n# NOTCH signaling and NOTCH3 biology\n## NOTCH receptors and ligands\n# Methods and analyses\n## Expression and prognosis assessment\n# Results and implications\n## Correlation with immune infiltration and tumor purity","[{\"question\":\"What is the main goal of this study on NOTCH3?\",\"answer\":\"To determine whether NOTCH3 can serve as a prognostic biomarker and to evaluate its correlation with immune infiltration in gastrointestinal cancers.\"},{\"question\":\"How was NOTCH3 expression analyzed?\",\"answer\":\"NOTCH3 expression was assessed using Western blot and PCR, along with Oncomine and the TIMER resource.\"},{\"question\":\"What prognostic relationship was found for NOTCH3?\",\"answer\":\"Higher NOTCH3 expression was significantly associated with poor clinical prognosis, as evaluated using Kaplan–Meier plotter, PrognoScan, and GEPIA.\"}]","NOTCH3 as a Prognostic Biomarker - and its Correlation with Immune Infiltration in Gastrointestinal Cancers | PDF",1790021033,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/2eb437db310986be6e957c09720d05b0.webp",983,1291,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c0eb317297a5e378420b1b6e7e011679.webp",982,1290,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/08e87f4c848cd9dc755508febcb0eb23.webp",981,1289,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/176c47972e3bc35560729b5df456370d.webp",980,1287]